Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Muqi Wang"'
Autor:
Yikai Wang, Muqi Wang, Chenrui Liu, Miao Hao, Wenjun Wang, Yaping Li, Juanjuan Shi, Xiaoli Jia, Xin Zhang, Shuangsuo Dang
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
AbstractBackground Cirrhosis is a disease that imposes a heavy burden worldwide, but its incidence varies widely by region. Therefore, we analysed data on the incidence and mortality of cirrhosis in 204 countries and territories from 1990–2019 and
Externí odkaz:
https://doaj.org/article/c6fdcec8696d43acab37ffd7ba674f86
Autor:
Muqi Wang, Huiling Deng, Yuan Chen, Yikai Wang, Yufeng Zhang, Chenrui Liu, Meng Zhang, Ting Li, Shuangsuo Dang, Yaping Li
Publikováno v:
Asian Pacific Journal of Tropical Medicine, Vol 17, Iss 4, Pp 173-183 (2024)
id="st1" To explore which pattern recognition receptors (PRRs) play a key role in the development of hand, foot, and mouth disease (HFMD) by analyzing PRR-associated genes. id="st2" We conducted a comparative analysis of PRR-associated gene expressio
Externí odkaz:
https://doaj.org/article/52dbdd437d8d48dfb564a0aa9f0a3a53
Autor:
Yikai Wang, Muqi Wang, Chenrui Liu, Miao Hao, Wenjun Wang, Yaping Li, Juanjuan Shi, Xin Zhang, Shuangsuo Dang
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Aspirin, as a widely used anti-inflammatory drug, has been shown to exert anti-cancer effects in a variety of cancers. PD-L1 is widely expressed in tumor cells and inhibits anti-tumor immunity. This study aims to clarify whether aspirin exer
Externí odkaz:
https://doaj.org/article/ab1213fc7282495fa83e6d06e25c0455
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2022 (2022)
Background. The use of statins is a potential protective factor against the development of hepatocellular carcinoma. Therefore, we conducted a meta-analysis to evaluate the contribution of statins to the risk of hepatocellular carcinoma. Methods. We
Externí odkaz:
https://doaj.org/article/0838e5490d684ce782e9f22b093b9fb5
Publikováno v:
Journal of Clinical Gastroenterology. 56:e293-e302
The use of aspirin is a potential protective factor against the development of hepatocellular carcinoma (HCC). Therefore, we conducted a meta-analysis to evaluate the contribution of aspirin to the risk of HCC.We searched for PubMed and EMBASE throug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8f4364170c145d47377deea9491a7fe
https://doi.org/10.1097/mcg.0000000000001693
https://doi.org/10.1097/mcg.0000000000001693
Publikováno v:
International journal of general medicine. 15
LiHong Xu1 *, Peng Wang2 *, YaNi Zhang,3 MuQi Wang,1 YaPing Li,1 WenHui Dang4 1Department of Infectious Diseases, the Second Affiliated Hospital of Xiâan Jiaotong University, Xiâan, Shaanxi Province, Peopleâs Republic of China;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::509a0b94cb26715c1f94336813888e6f
https://pubmed.ncbi.nlm.nih.gov/36196373
https://pubmed.ncbi.nlm.nih.gov/36196373